welbournes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension MSN/2024/107 Tier 2 medium impact Date of issue: 7th October 2024 Sodium fusidate (Fucidin®) 250mg tablets will be discontinued from mid-January 2025. Fusidic acid (Fucidin®) 250mg/5ml oral suspension will [...]

The post Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/10/2024) announced the following final list of price concessions for October 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £17.66 Apixaban 2.5mg tablets 60 £7.21 Apixaban [...]

The post October 2024 Price Concessions Final Update appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – November 2024 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Aqueous cream 100 £1.11 Clarithromycin 125mg/5ml oral suspension 70 £4.72 Clotrimazole 500mg [...]

The post October 2024 Price Concessions – 3rd Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Drug alert number: EL (24)A/51 Date issued: 28 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Company name: Kent Pharma UK Product [...]

The post MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) appeared first on Community Pharmacy England.